1. Broad requirement for terminal sialic acid residues and FcγRIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivo. Issue 5 (7th March 2014) Authors: Schwab, Inessa; Mihai, Sidonia; Seeling, Michaela; Kasperkiewicz, Michael; Ludwig, Ralf J.; Nimmerjahn, Falk Journal: European journal of immunology Issue: Volume 44:Issue 5(2014:May) Page Start: 1444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases. Issue 6 (8th November 2018) Authors: Wannick, Melanie; Bezdek, Siegfried; Guillen, Nathalie; Thieme, Markus; Meshrkey, Fibi; Mousavi, Sadegh; Seeling, Michaela; Nimmerjahn, Falk; Mócsai, Attila; Zillikens, Detlef; Sezin, Tanya; Sadik, Christian D. Journal: Pharmacology research & perspectives Issue: Volume 6:Issue 6(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗